|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
|
CN1452619A
(zh)
|
2000-07-26 |
2003-10-29 |
史密斯克莱·比奇曼公司 |
具有抗细菌活性的氨基哌啶喹啉和它们的氮杂等排的类似物
|
|
EP1719770A3
(en)
*
|
2000-09-21 |
2008-03-05 |
Smithkline Beecham Plc |
Quinoline derivatives as antibacterials
|
|
GB0031086D0
(en)
*
|
2000-12-20 |
2001-01-31 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0101577D0
(en)
*
|
2001-01-22 |
2001-03-07 |
Smithkline Beecham Plc |
Compounds
|
|
GB0112836D0
(en)
*
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0112834D0
(en)
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
US6632810B2
(en)
*
|
2001-06-29 |
2003-10-14 |
Kowa Co., Ltd. |
Cyclic diamine compound with condensed-ring groups
|
|
WO2003004480A2
(en)
*
|
2001-07-02 |
2003-01-16 |
Novo Nordisk A/S |
Substituted piperazine and diazepanes as histamine h3 receptor agonists
|
|
GB0118238D0
(en)
*
|
2001-07-26 |
2001-09-19 |
Smithkline Beecham Plc |
Medicaments
|
|
JP4445753B2
(ja)
|
2002-01-29 |
2010-04-07 |
グラクソ グループ リミテッド |
アミノピペリジン誘導体
|
|
US7109213B2
(en)
|
2002-01-29 |
2006-09-19 |
Glaxo Group Limited |
Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
|
|
CN1172919C
(zh)
*
|
2002-06-03 |
2004-10-27 |
上海医药工业研究院 |
芳烷醇哌嗪衍生物及其在制备抗抑郁症药物中的应用
|
|
AR040335A1
(es)
|
2002-06-26 |
2005-03-30 |
Glaxo Group Ltd |
Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
|
|
AR040336A1
(es)
|
2002-06-26 |
2005-03-30 |
Glaxo Group Ltd |
Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
|
|
GB0217294D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicaments
|
|
JP4602903B2
(ja)
*
|
2002-10-10 |
2010-12-22 |
モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー |
抗菌活性を有する新規化合物
|
|
ES2350977T3
(es)
|
2002-11-05 |
2011-01-28 |
Glaxo Group Limited |
Agentes antibacterianos.
|
|
AU2003303956A1
(en)
*
|
2002-11-05 |
2004-11-23 |
Smithkline Beecham Corporation |
Antibacterial agents
|
|
DE60324179D1
(de)
|
2002-12-04 |
2008-11-27 |
Glaxo Group Ltd |
Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
|
|
TW200507841A
(en)
*
|
2003-03-27 |
2005-03-01 |
Glaxo Group Ltd |
Antibacterial agents
|
|
EP1651643A4
(en)
*
|
2003-07-31 |
2008-10-08 |
Irm Llc |
BICYCLIC COMPOUNDS AND COMPOSITIONS USED AS PDF INHIBITORS
|
|
EP1784410A4
(en)
*
|
2004-08-09 |
2009-07-15 |
Glaxo Group Ltd |
ANTIBACTERIAL AGENTS
|
|
CA2589748C
(en)
*
|
2004-12-24 |
2013-08-13 |
Astrazeneca Ab |
Heterocyclic compounds as ccr2b antagonists
|
|
GB0428327D0
(en)
*
|
2004-12-24 |
2005-02-02 |
Astrazeneca Ab |
Method
|
|
WO2006074025A1
(en)
|
2004-12-30 |
2006-07-13 |
Janssen Pharmaceutica N.V. |
Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
|
|
JP2008528598A
(ja)
|
2005-01-25 |
2008-07-31 |
グラクソ グループ リミテッド |
抗菌剤
|
|
EP1845995A4
(en)
|
2005-01-25 |
2010-03-03 |
Glaxo Group Ltd |
ANTIBACTERIAL AGENTS
|
|
JP2008528586A
(ja)
|
2005-01-25 |
2008-07-31 |
グラクソ グループ リミテッド |
抗菌剤
|
|
WO2006081182A2
(en)
|
2005-01-25 |
2006-08-03 |
Glaxo Group Limited |
Antibacterial agents
|
|
JP2008528604A
(ja)
|
2005-01-25 |
2008-07-31 |
グラクソ グループ リミテッド |
抗菌剤
|
|
AU2006230364B2
(en)
|
2005-03-31 |
2012-09-13 |
Janssen Pharmaceutica N.V. |
Bicyclic pyrazole compounds as antibacterial agents
|
|
JP4902247B2
(ja)
*
|
2005-04-08 |
2012-03-21 |
富山化学工業株式会社 |
2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体
|
|
MY150958A
(en)
|
2005-06-16 |
2014-03-31 |
Astrazeneca Ab |
Compounds for the treatment of multi-drug resistant bacterial infections
|
|
EP2468743A1
(en)
|
2005-06-24 |
2012-06-27 |
Toyama Chemical Co., Ltd. |
Nitrogen-containing bicyclic compounds useful as antibacterial agents
|
|
GB0525957D0
(en)
*
|
2005-12-21 |
2006-02-01 |
Astrazeneca Ab |
Methods
|
|
JP2009524643A
(ja)
|
2006-01-26 |
2009-07-02 |
アクテリオン ファーマシューティカルズ リミテッド |
テトラヒドロピラン抗生物質
|
|
AU2007217474A1
(en)
*
|
2006-02-21 |
2007-08-30 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
WO2007100880A1
(en)
*
|
2006-02-28 |
2007-09-07 |
Amgen Inc. |
Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
|
|
CA2644850A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Amgen Inc. |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
|
ATE481406T1
(de)
|
2006-04-06 |
2010-10-15 |
Glaxo Group Ltd |
Pyrrolochinoxalinonderivate als antibakterielle mittel
|
|
US7709496B2
(en)
|
2006-04-06 |
2010-05-04 |
Glaxo Group Limited |
Antibacterial agents
|
|
MX2008014908A
(es)
|
2006-05-26 |
2009-05-13 |
Toyama Chemical Co Ltd |
Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo.
|
|
GB0613208D0
(en)
|
2006-07-03 |
2006-08-09 |
Glaxo Group Ltd |
Compounds
|
|
EP1992628A1
(en)
|
2007-05-18 |
2008-11-19 |
Glaxo Group Limited |
Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
|
|
PT2137196E
(pt)
*
|
2007-04-20 |
2010-12-16 |
Glaxo Group Ltd |
Compostos tricíclicos contendo azoto como agentes antibacterianos
|
|
US8354426B2
(en)
|
2007-11-26 |
2013-01-15 |
Toyama Chemical Co., Ltd. |
Naphthyridine derivative monohydrate and method for producing the same
|
|
EP2080761A1
(en)
|
2008-01-18 |
2009-07-22 |
Glaxo Group Limited |
Compounds
|
|
JP2012505866A
(ja)
|
2008-10-17 |
2012-03-08 |
グラクソ グループ リミテッド |
抗菌剤として使用される三環式窒素化合物
|
|
US8318940B2
(en)
|
2009-01-15 |
2012-11-27 |
Glaxo Group Limited |
Naphthyridin-2 (1 H)-one compounds useful as antibacterials
|
|
US8673920B2
(en)
|
2009-05-06 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
KR20120081119A
(ko)
*
|
2009-09-04 |
2012-07-18 |
잘리커스 파마슈티컬즈 리미티드 |
통증 및 간질 치료를 위한 치환된 헤테로고리 유도체
|
|
EP2632465B1
(en)
|
2010-10-27 |
2015-12-30 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
WO2012058134A1
(en)
|
2010-10-29 |
2012-05-03 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
GB201106817D0
(en)
|
2011-04-21 |
2011-06-01 |
Astex Therapeutics Ltd |
New compound
|
|
ES2605164T3
(es)
|
2011-08-19 |
2017-03-13 |
Merck Sharp & Dohme Corp. |
Inhibidores del canal de potasio de la médula renal externa
|
|
WO2013039802A1
(en)
|
2011-09-16 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2771005B1
(en)
|
2011-10-25 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2771004B1
(en)
|
2011-10-25 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2773199B1
(en)
|
2011-10-31 |
2019-04-10 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US9493474B2
(en)
|
2011-10-31 |
2016-11-15 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US9108947B2
(en)
|
2011-10-31 |
2015-08-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of the Renal Outer Medullary Potassium channel
|
|
US9206199B2
(en)
|
2011-12-16 |
2015-12-08 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
AR089929A1
(es)
|
2012-02-10 |
2014-10-01 |
Actelion Pharmaceuticals Ltd |
Proceso para manufacturar un derivado de naftiridina
|
|
AR092031A1
(es)
|
2012-07-26 |
2015-03-18 |
Merck Sharp & Dohme |
Inhibidores del canal de potasio medular externo renal
|
|
US9980973B2
(en)
|
2012-10-19 |
2018-05-29 |
Astex Therapeutics Limited |
Bicyclic heterocycle compounds and their uses in therapy
|
|
GB201218862D0
(en)
|
2012-10-19 |
2012-12-05 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
GB201218864D0
(en)
|
2012-10-19 |
2012-12-05 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
GB201218850D0
(en)
|
2012-10-19 |
2012-12-05 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
WO2014085210A1
(en)
|
2012-11-29 |
2014-06-05 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
WO2014099633A2
(en)
|
2012-12-19 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2956142B1
(en)
|
2013-02-18 |
2017-09-20 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
WO2014134306A1
(en)
|
2013-03-01 |
2014-09-04 |
Zalicus Pharmaceuticals, Ltd. |
Heterocyclic inhibitors of the sodium channel
|
|
US9765074B2
(en)
|
2013-03-15 |
2017-09-19 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US9751881B2
(en)
|
2013-07-31 |
2017-09-05 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
CN115368356B
(zh)
|
2013-12-20 |
2025-05-09 |
阿斯特克斯治疗有限公司 |
双环杂环化合物及其治疗用途
|
|
EP3110799A4
(en)
*
|
2014-02-27 |
2017-10-11 |
Epirus Biopharmaceuticals, Inc. |
Heterocyclic inhibitors of the sodium channel
|
|
AR101674A1
(es)
|
2014-08-22 |
2017-01-04 |
Glaxosmithkline Ip Dev Ltd |
Uso de un compuesto tricíclico que contiene nitrógeno
|
|
WO2016127358A1
(en)
|
2015-02-12 |
2016-08-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of renal outer medullary potassium channel
|
|
UY36851A
(es)
|
2015-08-16 |
2017-03-31 |
Glaxosmithkline Ip Dev Ltd |
Compuestos para uso en aplicaciones antibacterianas
|
|
US11884647B2
(en)
|
2019-10-18 |
2024-01-30 |
The Regents Of The University Of California |
Compounds and methods for targeting pathogenic blood vessels
|
|
US12590298B2
(en)
|
2019-10-18 |
2026-03-31 |
The Regents Of The University Of California |
Ex vivo tumor angiogenesis model
|